Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (8): 772-774.DOI: 10.3969/j.issn.1673-8640.2018.08.024
• Orginal Article • Previous Articles
Received:
2017-07-20
Online:
2018-08-30
Published:
2018-09-07
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.08.024
[1] | 姜健,宋学文,徐慧娟,等. 儿童非霍奇金淋巴瘤78 例临床及预后分析[J]. 临床儿科杂志,2015,33(8):715-719. |
[2] | 张蕊. 儿童神经母细胞瘤的临床特点及预后影响因素分析[J]. 中国实用神经疾病杂志,2015,18(10):69-70. |
[3] | 郭佳,朱易萍,高举,等. 儿童成熟B细胞非霍奇金淋巴瘤/急性淋巴细胞白血病43例临床及预后分析[J]. 中国实验血液学杂志,2016,24(1):72-79. |
[4] | 陈云平,鲍欣,陈里新. 小儿实体肿瘤基础及临床研究进展[J]. 吉林医学,2016,37(8):2050-2053. |
[5] | American Cancer Society.Cancer facts and figures 2014[M]. Atlanta:Society,2014:1. |
[6] | 林巍,吴润晖. 儿童骨髓增生异常综合症研究进展[J]. 中国实验血液学杂志,2015,23( 3):898-902. |
[7] | 周锦英. 儿童及青少年卵巢恶性肿瘤[J]. 国际妇产科学杂志,2015,42(1):17-20. |
[8] | 王珏,陆焱,顾中华,等. 7例骨髓增生异常/骨髓增殖性肿瘤的临床分析[J]. 检验医学,2014,29(10):1074-1075. |
[9] | 蓝海舰,解淑霞,赵文华,等. MDS转化为AML-M0一例[J]. 检验医学,2014,29(4):384-386. |
[10] | 李婵娟,赵海丰,赵伟鹏,等. 恶性实体瘤继发骨髓增生异常综合征急性髓系白血病11例分析[J]. 中国肿瘤临床,2015,42(7):373-377. |
[11] | 林鸣,肖胜军,金润铭. 小儿骨髓增生异常综合征28例临床诊断分析[J]. 中国实用儿科杂志,2014,29(11):871-873. |
[12] | 李燕,李雯雯,王晓敏. JAK2V617F基因突变与骨髓增殖性肿瘤疾病类型及疾病转化的相关性分析[J]. 中国全科医学,2012,15( 30):3486-3488. |
[13] | Baumann I,FÜhrer M,Behrendt S,et al.Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood:reproducibility of histopathological diagnostic criteria[J]. Histopathology,2012,61(1):10-17. |
[14] | Deeg H J,Bowen D T,Gore S D,et al.Myelodysplastic syndromes[M]. 2nd ed. Berlin:Springer Berlin Heidelberg,2013:41-72. |
[15] | 杨阳,傅丽娟,范翠华. 骨髓增生异常综合征合并胃癌1例并文献分析[J]. 吉林医学,2012,33(26):5824. |
[16] | 张俊美,王畅,王轶卓,等. 初治结肠癌合并骨髓增生异常综合征1例[J]. 中国老年学杂志,2014,34(1):215-217. |
[17] | 马薇,陈信义, 张雅月,等. 11例恶性肿瘤继发性骨髓增生异常综合征病例分析[J]. 现代生物医学进展,2014,140(9):1671-1675. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||